RETAVASE Trademark Information

Trademark by EKR THERAPEUTICS, LLC

cardiovascular agents for medical purposes, namely, a recombinant plasminogen activator compound for use in the management of acute myocardial infarction

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: 1/2/1997
First Use In Commerce: 1/2/1997
General Information
Word mark: RETAVASE
Status/Status Date:
REGISTERED
9/10/2019
Serial Number: 88341695
Filing Date: 3/15/2019
Registration Number: 5857585
Registration Date: 9/10/2019
Goods and Services: cardiovascular agents for medical purposes, namely, a recombinant plasminogen activator compound for use in the management of acute myocardial infarction
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 6/25/2019
Last Applicant/Owner:
EKR THERAPEUTICS, LLC
WILMINGTON, DE 19808
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
Chiesi USA Inc.
175 Regency Woods Place, Ste. 600
Cary NC 27518
Current Status:
REGISTERED
9/10/2019
Correspondent Search:
Jonathan Williams is a correspondent of RETAVASE trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on